Antibody-Mediated Rejection of Solid-Organ Allografts This review focuses on current
standards for management of antibody-mediated rejection in solid-organ transplant …

This meeting was organized by The Transplantation Society with the assistance of an
unconditional education grant from CSL Behring. CSL Behring had no involvement in the …

Cochrane, Maria Crespo Leiro, Anne Dipchand, Brian Feingold, Kathleen Grady, Edward
Horn, Maryl Johnson, Donna Mancini, Sean Pinney, Heather Ross, Kari Wujcik, Andreas …

Background Late antibody-mediated rejection (ABMR) is a leading cause of transplant
failure. Blocking IL-6 has been proposed as a promising therapeutic strategy. Methods We …

Objective To develop and validate an integrative system to predict long term kidney allograft
failure. Design International cohort study. Setting Three cohorts including kidney transplant …

Despite advances in post-transplant management, the long-term survival rate of kidney
grafts and patients has not improved as approximately forty percent of transplants fails within …

Immunosuppression regimens used in solid organ transplant have evolved significantly over
the past 70 years in the United States. Early immunosuppression and targets for allograft …

Abstract The Sensitization in Transplantation: Assessment of Risk workgroup is a
collaborative effort of the American Society of Transplantation and the American Society of …

Heart transplantation is advocated in selected patients with advanced heart failure in the
absence of contraindications. Principal challenges in heart transplantation centre around an …

Potent immunosuppressive drugs have been introduced into clinical care for solid organ
transplant recipients. It is now time to guide these drugs on an individual level to optimize …